Industry Research Reports

Home > Reports > Medical Care > Subcutaneous Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Subcutaneous Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 110 Pages

Report ld: 2333897

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine and goserelin. Subcutaneous, as opposed to intravenous, injection of recreational drugs is referred to as "skin popping". Subcutaneous administration may be abbreviated as SC, SQ, sub-cu, sub-Q, SubQ, or subcut. Subcut is the preferred abbreviation for patient safety.

The global market for Subcutaneous Injection was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Subcutaneous Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Subcutaneous Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Subcutaneous Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Subcutaneous Injection include Becton Dickinson, Daiichi Sankyo, Sanofi, Roche, GSK, Eli Lilly, Asahi Kasei Pharma, Takeda Pharmaceutical and Antares Pharma, Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Injection, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Subcutaneous Injection by region & country, by Type, and by Application.

The Subcutaneous Injection market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Injection.

Market Segmentation

Report Metric
Details
Report Title
Subcutaneous Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Subcutaneous Injection Companies Covered
Becton Dickinson, Daiichi Sankyo, Sanofi, Roche, GSK, Eli Lilly, Asahi Kasei Pharma, Takeda Pharmaceutical, Antares Pharma, Inc., Eisai Co.，Ltd, Chugai Pharmaceutical, Endo International, PenJet Corporation, Aspen Medical Group
Global Subcutaneous Injection Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Subcutaneous Injection Market, Segment by Type
Subcutaneous Injection Equipment

Subcutaneous Injection Drug

Others
Global Subcutaneous Injection Market, Segment by Application
Hospital

Clinic

Laboratory

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Subcutaneous Injection manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Subcutaneous Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Subcutaneous Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Subcutaneous Injection Product Introduction
    1.2 Global Subcutaneous Injection Market Size Forecast
    1.3 Subcutaneous Injection Market Trends & Drivers
        1.3.1 Subcutaneous Injection Industry Trends
        1.3.2 Subcutaneous Injection Market Drivers & Opportunity
        1.3.3 Subcutaneous Injection Market Challenges
        1.3.4 Subcutaneous Injection Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Subcutaneous Injection Players Revenue Ranking (2023)
    2.2 Global Subcutaneous Injection Revenue by Company (2019-2024)
    2.3 Key Companies Subcutaneous Injection Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Subcutaneous Injection Product Offered
    2.5 Key Companies Time to Begin Mass Production of Subcutaneous Injection
    2.6 Subcutaneous Injection Market Competitive Analysis
        2.6.1 Subcutaneous Injection Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Subcutaneous Injection Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Injection as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Subcutaneous Injection Equipment
        3.1.2 Subcutaneous Injection Drug
        3.1.3 Others
    3.2 Global Subcutaneous Injection Sales Value by Type
        3.2.1 Global Subcutaneous Injection Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Subcutaneous Injection Sales Value, by Type (2019-2030)
        3.2.3 Global Subcutaneous Injection Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Clinic
        4.1.3 Laboratory
        4.1.4 Others
    4.2 Global Subcutaneous Injection Sales Value by Application
        4.2.1 Global Subcutaneous Injection Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Subcutaneous Injection Sales Value, by Application (2019-2030)
        4.2.3 Global Subcutaneous Injection Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Subcutaneous Injection Sales Value by Region
        5.1.1 Global Subcutaneous Injection Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Subcutaneous Injection Sales Value by Region (2019-2024)
        5.1.3 Global Subcutaneous Injection Sales Value by Region (2025-2030)
        5.1.4 Global Subcutaneous Injection Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Subcutaneous Injection Sales Value, 2019-2030
        5.2.2 North America Subcutaneous Injection Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Subcutaneous Injection Sales Value, 2019-2030
        5.3.2 Europe Subcutaneous Injection Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Subcutaneous Injection Sales Value, 2019-2030
        5.4.2 Asia Pacific Subcutaneous Injection Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Subcutaneous Injection Sales Value, 2019-2030
        5.5.2 South America Subcutaneous Injection Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Subcutaneous Injection Sales Value, 2019-2030
        5.6.2 Middle East & Africa Subcutaneous Injection Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Subcutaneous Injection Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Subcutaneous Injection Sales Value
    6.3 United States
        6.3.1 United States Subcutaneous Injection Sales Value, 2019-2030
        6.3.2 United States Subcutaneous Injection Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Subcutaneous Injection Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Subcutaneous Injection Sales Value, 2019-2030
        6.4.2 Europe Subcutaneous Injection Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Subcutaneous Injection Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Subcutaneous Injection Sales Value, 2019-2030
        6.5.2 China Subcutaneous Injection Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Subcutaneous Injection Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Subcutaneous Injection Sales Value, 2019-2030
        6.6.2 Japan Subcutaneous Injection Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Subcutaneous Injection Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Subcutaneous Injection Sales Value, 2019-2030
        6.7.2 South Korea Subcutaneous Injection Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Subcutaneous Injection Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Subcutaneous Injection Sales Value, 2019-2030
        6.8.2 Southeast Asia Subcutaneous Injection Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Subcutaneous Injection Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Subcutaneous Injection Sales Value, 2019-2030
        6.9.2 India Subcutaneous Injection Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Subcutaneous Injection Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Becton Dickinson
        7.1.1 Becton Dickinson Profile
        7.1.2 Becton Dickinson Main Business
        7.1.3 Becton Dickinson Subcutaneous Injection Products, Services and Solutions
        7.1.4 Becton Dickinson Subcutaneous Injection Revenue (US$ Million) & (2019-2024)
        7.1.5 Becton Dickinson Recent Developments
    7.2 Daiichi Sankyo
        7.2.1 Daiichi Sankyo Profile
        7.2.2 Daiichi Sankyo Main Business
        7.2.3 Daiichi Sankyo Subcutaneous Injection Products, Services and Solutions
        7.2.4 Daiichi Sankyo Subcutaneous Injection Revenue (US$ Million) & (2019-2024)
        7.2.5 Daiichi Sankyo Recent Developments
    7.3 Sanofi
        7.3.1 Sanofi Profile
        7.3.2 Sanofi Main Business
        7.3.3 Sanofi Subcutaneous Injection Products, Services and Solutions
        7.3.4 Sanofi Subcutaneous Injection Revenue (US$ Million) & (2019-2024)
        7.3.5 Roche Recent Developments
    7.4 Roche
        7.4.1 Roche Profile
        7.4.2 Roche Main Business
        7.4.3 Roche Subcutaneous Injection Products, Services and Solutions
        7.4.4 Roche Subcutaneous Injection Revenue (US$ Million) & (2019-2024)
        7.4.5 Roche Recent Developments
    7.5 GSK
        7.5.1 GSK Profile
        7.5.2 GSK Main Business
        7.5.3 GSK Subcutaneous Injection Products, Services and Solutions
        7.5.4 GSK Subcutaneous Injection Revenue (US$ Million) & (2019-2024)
        7.5.5 GSK Recent Developments
    7.6 Eli Lilly
        7.6.1 Eli Lilly Profile
        7.6.2 Eli Lilly Main Business
        7.6.3 Eli Lilly Subcutaneous Injection Products, Services and Solutions
        7.6.4 Eli Lilly Subcutaneous Injection Revenue (US$ Million) & (2019-2024)
        7.6.5 Eli Lilly Recent Developments
    7.7 Asahi Kasei Pharma
        7.7.1 Asahi Kasei Pharma Profile
        7.7.2 Asahi Kasei Pharma Main Business
        7.7.3 Asahi Kasei Pharma Subcutaneous Injection Products, Services and Solutions
        7.7.4 Asahi Kasei Pharma Subcutaneous Injection Revenue (US$ Million) & (2019-2024)
        7.7.5 Asahi Kasei Pharma Recent Developments
    7.8 Takeda Pharmaceutical
        7.8.1 Takeda Pharmaceutical Profile
        7.8.2 Takeda Pharmaceutical Main Business
        7.8.3 Takeda Pharmaceutical Subcutaneous Injection Products, Services and Solutions
        7.8.4 Takeda Pharmaceutical Subcutaneous Injection Revenue (US$ Million) & (2019-2024)
        7.8.5 Takeda Pharmaceutical Recent Developments
    7.9 Antares Pharma, Inc.
        7.9.1 Antares Pharma, Inc. Profile
        7.9.2 Antares Pharma, Inc. Main Business
        7.9.3 Antares Pharma, Inc. Subcutaneous Injection Products, Services and Solutions
        7.9.4 Antares Pharma, Inc. Subcutaneous Injection Revenue (US$ Million) & (2019-2024)
        7.9.5 Antares Pharma, Inc. Recent Developments
    7.10 Eisai Co.，Ltd
        7.10.1 Eisai Co.，Ltd Profile
        7.10.2 Eisai Co.，Ltd Main Business
        7.10.3 Eisai Co.，Ltd Subcutaneous Injection Products, Services and Solutions
        7.10.4 Eisai Co.，Ltd Subcutaneous Injection Revenue (US$ Million) & (2019-2024)
        7.10.5 Eisai Co.，Ltd Recent Developments
    7.11 Chugai Pharmaceutical
        7.11.1 Chugai Pharmaceutical Profile
        7.11.2 Chugai Pharmaceutical Main Business
        7.11.3 Chugai Pharmaceutical Subcutaneous Injection Products, Services and Solutions
        7.11.4 Chugai Pharmaceutical Subcutaneous Injection Revenue (US$ Million) & (2019-2024)
        7.11.5 Chugai Pharmaceutical Recent Developments
    7.12 Endo International
        7.12.1 Endo International Profile
        7.12.2 Endo International Main Business
        7.12.3 Endo International Subcutaneous Injection Products, Services and Solutions
        7.12.4 Endo International Subcutaneous Injection Revenue (US$ Million) & (2019-2024)
        7.12.5 Endo International Recent Developments
    7.13 PenJet Corporation
        7.13.1 PenJet Corporation Profile
        7.13.2 PenJet Corporation Main Business
        7.13.3 PenJet Corporation Subcutaneous Injection Products, Services and Solutions
        7.13.4 PenJet Corporation Subcutaneous Injection Revenue (US$ Million) & (2019-2024)
        7.13.5 PenJet Corporation Recent Developments
    7.14 Aspen Medical Group
        7.14.1 Aspen Medical Group Profile
        7.14.2 Aspen Medical Group Main Business
        7.14.3 Aspen Medical Group Subcutaneous Injection Products, Services and Solutions
        7.14.4 Aspen Medical Group Subcutaneous Injection Revenue (US$ Million) & (2019-2024)
        7.14.5 Aspen Medical Group Recent Developments

 8 Industry Chain Analysis
    8.1 Subcutaneous Injection Industrial Chain
    8.2 Subcutaneous Injection Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Subcutaneous Injection Sales Model
        8.5.2 Sales Channel
        8.5.3 Subcutaneous Injection Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Subcutaneous Injection Market Trends
    Table 2. Subcutaneous Injection Market Drivers & Opportunity
    Table 3. Subcutaneous Injection Market Challenges
    Table 4. Subcutaneous Injection Market Restraints
    Table 5. Global Subcutaneous Injection Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Subcutaneous Injection Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Subcutaneous Injection Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Subcutaneous Injection Product Type
    Table 9. Key Companies Time to Begin Mass Production of Subcutaneous Injection
    Table 10. Global Subcutaneous Injection Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Injection as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Subcutaneous Injection Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Subcutaneous Injection Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Subcutaneous Injection Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Subcutaneous Injection Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Subcutaneous Injection Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Subcutaneous Injection Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Subcutaneous Injection Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Subcutaneous Injection Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Subcutaneous Injection Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Subcutaneous Injection Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Subcutaneous Injection Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Subcutaneous Injection Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Subcutaneous Injection Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Subcutaneous Injection Sales Value by Region (2019-2024) & (%)
    Table 27. Global Subcutaneous Injection Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Subcutaneous Injection Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Subcutaneous Injection Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Subcutaneous Injection Sales Value, (2025-2030) & (US$ Million)
    Table 31. Becton Dickinson Basic Information List
    Table 32. Becton Dickinson Description and Business Overview
    Table 33. Becton Dickinson Subcutaneous Injection Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Subcutaneous Injection Business of Becton Dickinson (2019-2024)
    Table 35. Becton Dickinson Recent Developments
    Table 36. Daiichi Sankyo Basic Information List
    Table 37. Daiichi Sankyo Description and Business Overview
    Table 38. Daiichi Sankyo Subcutaneous Injection Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Subcutaneous Injection Business of Daiichi Sankyo (2019-2024)
    Table 40. Daiichi Sankyo Recent Developments
    Table 41. Sanofi Basic Information List
    Table 42. Sanofi Description and Business Overview
    Table 43. Sanofi Subcutaneous Injection Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Subcutaneous Injection Business of Sanofi (2019-2024)
    Table 45. Sanofi Recent Developments
    Table 46. Roche Basic Information List
    Table 47. Roche Description and Business Overview
    Table 48. Roche Subcutaneous Injection Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Subcutaneous Injection Business of Roche (2019-2024)
    Table 50. Roche Recent Developments
    Table 51. GSK Basic Information List
    Table 52. GSK Description and Business Overview
    Table 53. GSK Subcutaneous Injection Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Subcutaneous Injection Business of GSK (2019-2024)
    Table 55. GSK Recent Developments
    Table 56. Eli Lilly Basic Information List
    Table 57. Eli Lilly Description and Business Overview
    Table 58. Eli Lilly Subcutaneous Injection Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Subcutaneous Injection Business of Eli Lilly (2019-2024)
    Table 60. Eli Lilly Recent Developments
    Table 61. Asahi Kasei Pharma Basic Information List
    Table 62. Asahi Kasei Pharma Description and Business Overview
    Table 63. Asahi Kasei Pharma Subcutaneous Injection Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Subcutaneous Injection Business of Asahi Kasei Pharma (2019-2024)
    Table 65. Asahi Kasei Pharma Recent Developments
    Table 66. Takeda Pharmaceutical Basic Information List
    Table 67. Takeda Pharmaceutical Description and Business Overview
    Table 68. Takeda Pharmaceutical Subcutaneous Injection Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Subcutaneous Injection Business of Takeda Pharmaceutical (2019-2024)
    Table 70. Takeda Pharmaceutical Recent Developments
    Table 71. Antares Pharma, Inc. Basic Information List
    Table 72. Antares Pharma, Inc. Description and Business Overview
    Table 73. Antares Pharma, Inc. Subcutaneous Injection Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Subcutaneous Injection Business of Antares Pharma, Inc. (2019-2024)
    Table 75. Antares Pharma, Inc. Recent Developments
    Table 76. Eisai Co.，Ltd Basic Information List
    Table 77. Eisai Co.，Ltd Description and Business Overview
    Table 78. Eisai Co.，Ltd Subcutaneous Injection Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Subcutaneous Injection Business of Eisai Co.，Ltd (2019-2024)
    Table 80. Eisai Co.，Ltd Recent Developments
    Table 81. Chugai Pharmaceutical Basic Information List
    Table 82. Chugai Pharmaceutical Description and Business Overview
    Table 83. Chugai Pharmaceutical Subcutaneous Injection Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Subcutaneous Injection Business of Chugai Pharmaceutical (2019-2024)
    Table 85. Chugai Pharmaceutical Recent Developments
    Table 86. Endo International Basic Information List
    Table 87. Endo International Description and Business Overview
    Table 88. Endo International Subcutaneous Injection Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Subcutaneous Injection Business of Endo International (2019-2024)
    Table 90. Endo International Recent Developments
    Table 91. PenJet Corporation Basic Information List
    Table 92. PenJet Corporation Description and Business Overview
    Table 93. PenJet Corporation Subcutaneous Injection Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Subcutaneous Injection Business of PenJet Corporation (2019-2024)
    Table 95. PenJet Corporation Recent Developments
    Table 96. Aspen Medical Group Basic Information List
    Table 97. Aspen Medical Group Description and Business Overview
    Table 98. Aspen Medical Group Subcutaneous Injection Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Subcutaneous Injection Business of Aspen Medical Group (2019-2024)
    Table 100. Aspen Medical Group Recent Developments
    Table 101. Key Raw Materials Lists
    Table 102. Raw Materials Key Suppliers Lists
    Table 103. Subcutaneous Injection Downstream Customers
    Table 104. Subcutaneous Injection Distributors List
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
    Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Subcutaneous Injection Product Picture
    Figure 2. Global Subcutaneous Injection Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Subcutaneous Injection Sales Value (2019-2030) & (US$ Million)
    Figure 4. Subcutaneous Injection Report Years Considered
    Figure 5. Global Subcutaneous Injection Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Subcutaneous Injection Revenue in 2023
    Figure 7. Subcutaneous Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Subcutaneous Injection Equipment Picture
    Figure 9. Subcutaneous Injection Drug Picture
    Figure 10. Others Picture
    Figure 11. Global Subcutaneous Injection Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Subcutaneous Injection Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Hospital
    Figure 14. Product Picture of Clinic
    Figure 15. Product Picture of Laboratory
    Figure 16. Product Picture of Others
    Figure 17. Global Subcutaneous Injection Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Subcutaneous Injection Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Subcutaneous Injection Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Subcutaneous Injection Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Subcutaneous Injection Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Subcutaneous Injection Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Subcutaneous Injection Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Subcutaneous Injection Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Subcutaneous Injection Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Subcutaneous Injection Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Subcutaneous Injection Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Subcutaneous Injection Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Subcutaneous Injection Sales Value (%), (2019-2030)
    Figure 30. United States Subcutaneous Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Subcutaneous Injection Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Subcutaneous Injection Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Subcutaneous Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Subcutaneous Injection Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Subcutaneous Injection Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Subcutaneous Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Subcutaneous Injection Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Subcutaneous Injection Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Subcutaneous Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Subcutaneous Injection Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Subcutaneous Injection Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Subcutaneous Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Subcutaneous Injection Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Subcutaneous Injection Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Subcutaneous Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Subcutaneous Injection Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Subcutaneous Injection Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Subcutaneous Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Subcutaneous Injection Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Subcutaneous Injection Sales Value by Application (%), 2023 VS 2030
    Figure 51. Subcutaneous Injection Industrial Chain
    Figure 52. Subcutaneous Injection Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation

Description

A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine and goserelin. Subcutaneous, as opposed to intravenous, injection of recreational drugs is referred to as "skin popping". Subcutaneous administration may be abbreviated as SC, SQ, sub-cu, sub-Q, SubQ, or subcut. Subcut is the preferred abbreviation for patient safety.

The global market for Subcutaneous Injection was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Subcutaneous Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Subcutaneous Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Subcutaneous Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Subcutaneous Injection include Becton Dickinson, Daiichi Sankyo, Sanofi, Roche, GSK, Eli Lilly, Asahi Kasei Pharma, Takeda Pharmaceutical and Antares Pharma, Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Injection, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Subcutaneous Injection by region & country, by Type, and by Application.

The Subcutaneous Injection market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Injection.

Market Segmentation